Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.44

-1.7%

Nov 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (1543)	3/23/1999 12:43:00 PM
From: Anthony Wong	Read Replies (1) of 1722

Growth Hormone Norditropin Approved In Denmark BAGSVAERD, DENMARK -- March 23, 1999 -- Novo Nordisk A/S has received approval from the Danish health authorities (Laegemiddelstyrelsen) for Norditropin(R) SimpleXx(TM) (somatropin [rDNA origin] for injection) the company's liquid growth hormone preparation. This is the first approval of Norditropin SimpleXx and the first approval of a liquid growth hormone product outside the US. Norditropin SimpleXx will be launched together with a newly developed pen system -- NordiPen(TM) to make daily injections even more convenient. The Danish approval is expected to be followed by a formal European Union (EU) approval and launch in a number of European countries during 1999. The product was filed in Japan in February and US filing is expected later this year.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next